Patents by Inventor Kenneth Robert Bundell

Kenneth Robert Bundell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040048381
    Abstract: The invention provides a two component system for in vitro cloning of a heterologous polynucleotide into adenoviral DNA. The first component is an insert donor comprising a heterologous polynucleotide encoding a heterologous polypeptide. The second component is a vector donor comprising an adenovirus genome and an expression cassette. The insert donor and vector donor are adapted for site specific recombination using recombination sites from phage lambda for insertion of the heterologous polynucleotide into the expression cassette capable of forming an adenoviral expression clone in vitro in the presence of a suitable recombination mediator protein or proteins. The invention also provides a method of making recombinant adenovirus and use of the first and second components in such a method.
    Type: Application
    Filed: May 8, 2003
    Publication date: March 11, 2004
    Inventors: Johann Winkler, Kenneth Robert Bundell
  • Patent number: 6537779
    Abstract: An improved T7 based promoter-driven protein expression system comprising an operator sequence downstream of the T7 promoter sequence, and having a further operator sequence upstream of the T7 promoter sequence.
    Type: Grant
    Filed: April 3, 2000
    Date of Patent: March 25, 2003
    Assignee: Zeneca Limited
    Inventors: Bhupendra Vallabh Kara, David Pioli, Kenneth Robert Bundell, Robert Craig Hockney